优质护理干预对肝病患者睡眠质量及生命质量的改善效果观察(1)
摘要目的：观察优质护理干预对肝病患者睡眠质量及生命质量的临床改善效果。方法：选取2018年7月至2019年7月厦门大学附属第一医院感染科收治的肝病患者140例作为研究对象，按照门诊号随机分为对照组和观察组，每组70例。对照组进行常规护理，观察组则进行优质护理干预。比较2组的睡眠质量[匹兹堡睡眠质量指数(PSQI)]与生命质量[生命质量综合评定问卷(GQOLI74)]。结果：观察组的PSQI评分均显著低于对照组，GQOLI74评分均显著高于对照组，差异有统计学意义(P<005)。结论：优质护理干预可显著地改善肝病患者的睡眠质量及生命质量，具有较高的应用价值。
关键词肝病;优质护理干预;睡眠质量;生命质量
Observation on the Effect of High quality nursing Intervention for Sleep Quality and Life Quality of Patients with Liver Diseases
WU Jian
(Department of Infection，First Affiliated Hospital of Xiamen University，Xiamen 361000，China)
AbstractObjective：To observe the clinical improvement effect of high quality nursing intervention for sleep quality and life quality of patients with liver diseasesMethods：A total of 140 patients with liver diseases in First Affiliated Hospital of Xiamen University from July 2018 to July 2019were randomly divided into control group and observation group with 70 cases in each group according to the outpatient numberThe control group were with routine nursing，and the observation group were with high quality nursing interventionThen the sleep quality[Pittsburgh Sleep Quality Index(PSQI)]and life quality[Greneric Quarity of Life Inventor74(GQOLI74)]of two groups were comparedResults：The PSQI scores of observation group were significantly lower than those of control group，the GQOLI74 scores were significantly higher than those of control group，there were statistically significant differences(P<005)Conclusion：The high quality nursing intervention can significantly improve the sleep quality and life quality of patients with liver diseases，so its application value is higher.
KeywordsLiver disease; High quality nursing intervention; Sleep quality;Life quality
中圖分类号：R4735;R33863文献标识码：Adoi：10.3969/j.issn.2095-7130.2020.06.046
对于肝病患者而言，受到疾病所致的多种临床症状影响，以及疾病所造成的心理负担，极易在睡眠等方面存在一定的问题，并直接导致患者生命质量的下降[1]。为此，在对肝病患者实施临床护理的时候，还应注重上述问题的干预，可通过开展有针对性的优质护理干预来达到改善患者睡眠状况，提高其生命质量等效果[2]。本文选取120例肝病患者，对其应用睡眠质量及生命质量的优质护理干预，并观察所收到的临床疗效，现将结果报道如下。
1资料与方法
11一般资料选取2018年7月至2019年7月厦门大学附属第一医院感染科收治的肝病患者140例作为研究对象，按照门诊号随机分为对照组和观察组，每组70例。对照组中男39例，女31例，年龄25～76岁，平均年龄(5698±607)岁;病程6个月至9年，平均病程(539±125)年;疾病类型：慢性乙型肝炎34例，肝硬化22例，甲肝8例，其他肝病6例;婚姻状况：已婚58例，未婚12例。观察组中男41例，女29例，年龄26～78岁，平均年龄(5724±574)岁;病程6个月至9年，平均病程(542±131)年;疾病类型：慢性乙型肝炎36例，肝硬化20例，甲肝9例，其他肝病5例;婚姻状况：已婚60例，未婚10例。2组的一般资料比较，差异无统计学意义(P>005)，具有可比性。
12纳入标准1)均为确诊肝病患者;2)本研究经过我院伦理委员会批准并经患者及其家属知情同意。, 百拇医药(巫健)
关键词肝病;优质护理干预;睡眠质量;生命质量
Observation on the Effect of High quality nursing Intervention for Sleep Quality and Life Quality of Patients with Liver Diseases
WU Jian
(Department of Infection，First Affiliated Hospital of Xiamen University，Xiamen 361000，China)
AbstractObjective：To observe the clinical improvement effect of high quality nursing intervention for sleep quality and life quality of patients with liver diseasesMethods：A total of 140 patients with liver diseases in First Affiliated Hospital of Xiamen University from July 2018 to July 2019were randomly divided into control group and observation group with 70 cases in each group according to the outpatient numberThe control group were with routine nursing，and the observation group were with high quality nursing interventionThen the sleep quality[Pittsburgh Sleep Quality Index(PSQI)]and life quality[Greneric Quarity of Life Inventor74(GQOLI74)]of two groups were comparedResults：The PSQI scores of observation group were significantly lower than those of control group，the GQOLI74 scores were significantly higher than those of control group，there were statistically significant differences(P<005)Conclusion：The high quality nursing intervention can significantly improve the sleep quality and life quality of patients with liver diseases，so its application value is higher.
KeywordsLiver disease; High quality nursing intervention; Sleep quality;Life quality
中圖分类号：R4735;R33863文献标识码：Adoi：10.3969/j.issn.2095-7130.2020.06.046
对于肝病患者而言，受到疾病所致的多种临床症状影响，以及疾病所造成的心理负担，极易在睡眠等方面存在一定的问题，并直接导致患者生命质量的下降[1]。为此，在对肝病患者实施临床护理的时候，还应注重上述问题的干预，可通过开展有针对性的优质护理干预来达到改善患者睡眠状况，提高其生命质量等效果[2]。本文选取120例肝病患者，对其应用睡眠质量及生命质量的优质护理干预，并观察所收到的临床疗效，现将结果报道如下。
1资料与方法
11一般资料选取2018年7月至2019年7月厦门大学附属第一医院感染科收治的肝病患者140例作为研究对象，按照门诊号随机分为对照组和观察组，每组70例。对照组中男39例，女31例，年龄25～76岁，平均年龄(5698±607)岁;病程6个月至9年，平均病程(539±125)年;疾病类型：慢性乙型肝炎34例，肝硬化22例，甲肝8例，其他肝病6例;婚姻状况：已婚58例，未婚12例。观察组中男41例，女29例，年龄26～78岁，平均年龄(5724±574)岁;病程6个月至9年，平均病程(542±131)年;疾病类型：慢性乙型肝炎36例，肝硬化20例，甲肝9例，其他肝病5例;婚姻状况：已婚60例，未婚10例。2组的一般资料比较，差异无统计学意义(P>005)，具有可比性。
12纳入标准1)均为确诊肝病患者;2)本研究经过我院伦理委员会批准并经患者及其家属知情同意。, 百拇医药(巫健)